{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T07:27:38Z","timestamp":1768894058283,"version":"3.49.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim Corp USA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017346","name":"Boehringer Ingelheim Japan","doi-asserted-by":"publisher","award":["B32012"],"award-info":[{"award-number":["B32012"]}],"id":[{"id":"10.13039\/100017346","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.rmed.2024.107721","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T07:14:57Z","timestamp":1720163697000},"page":"107721","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Prognostic impact of cytokines and chemokines in bronchoalveolar lavage fluid on acute exacerbation of fibrosing interstitial lung disease"],"prefix":"10.1016","volume":"231","author":[{"given":"Katsuyuki","family":"Furuta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0615-3000","authenticated-orcid":false,"given":"Daichi","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5184-6837","authenticated-orcid":false,"given":"Atsushi","family":"Matsunashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Shibaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinnosuke","family":"Taniya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6974-9480","authenticated-orcid":false,"given":"Masanori","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6269-5843","authenticated-orcid":false,"given":"Yuri","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuma","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3524-6217","authenticated-orcid":false,"given":"Keisuke","family":"Tomii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7342-0853","authenticated-orcid":false,"given":"Nobuyuki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.rmed.2024.107721_bib1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2024.107721_bib2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1164\/rccm.201604-0801CI","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis. An international working group report","volume":"194","author":"Collard","year":"2016","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.rmed.2024.107721_bib3","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0071-2018","article-title":"Acute exacerbations of progressive-fibrosing interstitial lung diseases","volume":"27","author":"Kolb","year":"2018","journal-title":"Eur. Respir. Rev."},{"key":"10.1016\/j.rmed.2024.107721_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/resp.13682","article-title":"Acute exacerbations of fibrotic interstitial lung diseases","volume":"25","author":"Suzuki","year":"2020","journal-title":"Respirology"},{"key":"10.1016\/j.rmed.2024.107721_bib5","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"For the INBUILD Trial Investigators Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2024.107721_bib6","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"For the INPULSIS Trial Investigators* Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.rmed.2024.107721_bib7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.3389\/fmed.2017.00176","article-title":"Acute exacerbation in interstitial lung disease","volume":"4","author":"Leuschner","year":"2017","journal-title":"Front. Med."},{"key":"10.1016\/j.rmed.2024.107721_bib8","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.chest.2015.12.026","article-title":"Patients with fibrotic interstitial lung disease hospitalized for acute respiratory worsening: a large cohort analysis","volume":"149","author":"Moua","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2024.107721_bib9","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.2169\/internalmedicine.7875-16","article-title":"The activities of daily living after an acute exacerbation of idiopathic pulmonary fibrosis","volume":"56","author":"Koyama","year":"2017","journal-title":"Intern. Med."},{"key":"10.1016\/j.rmed.2024.107721_bib10","article-title":"Systematic review and meta-analysis of prognostic factors of acute exacerbation of idiopathic pulmonary fibrosis","volume":"10","author":"Kamiya","year":"2010","journal-title":"BMJ Open"},{"key":"10.1016\/j.rmed.2024.107721_bib11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1183\/09031936.00159709","article-title":"Acute exacerbation of idiopathic pulmonary fibrosis: incidence, risk factors and outcome","volume":"37","author":"Song","year":"2011","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2024.107721_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41572-019-0069-0","article-title":"Acute respiratory distress syndrome","volume":"5","author":"Matthay","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10.1016\/j.rmed.2024.107721_bib13","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1007\/s00432-021-03750-z","article-title":"Analysis of cytokines in serum and bronchoalveolar lavage fluid in patients with immune-checkpoint inhibitor-associated pneumonitis: a cross-sectional case-control study","volume":"148","author":"Kowalski","year":"2022","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.rmed.2024.107721_bib14","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.intimp.2019.02.039","article-title":"Prognostic value of IFN-\u03b3, sCD163, CCL2 and CXCL10 involved in acute exacerbation of idiopathic pulmonary fibrosis","volume":"70","author":"Gui","year":"2019","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.rmed.2024.107721_bib15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1365-3083.2008.02222.x","article-title":"Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases","volume":"69","author":"Vasakova","year":"2009","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.rmed.2024.107721_bib16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.biocel.2004.06.017","article-title":"MMP-1: the elder of the family","volume":"37","author":"Pardo","year":"2005","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.rmed.2024.107721_bib17","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1186\/1755-1536-5-S1-S9","article-title":"Role of matrix metaloproteases in idiopathic pulmonary fibrosis","volume":"6","author":"Pardo","year":"2012","journal-title":"Fibrogenesis Tissue Repair"},{"key":"10.1016\/j.rmed.2024.107721_bib18","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.humpath.2005.11.023","article-title":"Matrix metalloproteinases and matrix metalloproteinase inhibitors in acute lung injury","volume":"37","author":"Fligiel","year":"2006","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.rmed.2024.107721_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/s41584-020-0419-z","article-title":"Translating IL-6 biology into effective treatments","volume":"16","author":"Choy","year":"2020","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.rmed.2024.107721_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.cyto.2017.08.019","article-title":"High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations","volume":"102","author":"Papiris","year":"2018","journal-title":"Cytokine"},{"key":"10.1016\/j.rmed.2024.107721_bib21","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00408-017-9993-5","article-title":"Blood biomarkers in idiopathic pulmonary fibrosis","volume":"195","author":"Guiot","year":"2017","journal-title":"Lung"},{"key":"10.1016\/j.rmed.2024.107721_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.CCM.0000149854.61192.DC","article-title":"The NHLBI Acute Respiratory Distress Syndrome Clinical Trials Network, Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury","volume":"33","author":"Parsons","year":"2005","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.rmed.2024.107721_bib23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.rmed.2024.107721_bib24","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.3390\/ijms20092218","article-title":"Monocyte chemoattractant protein-1, a possible biomarker of multiorgan failure and mortality in ventilator-associated pneumonia","volume":"20","author":"Li","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.rmed.2024.107721_bib25","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1182\/blood.V56.6.947.947","article-title":"The nature and action of granulocyte-macrophage colony stimulating factors","volume":"56","author":"Burgess","year":"1980","journal-title":"Blood"},{"key":"10.1016\/j.rmed.2024.107721_bib26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2147\/ITT.S262566","article-title":"GM-CSF: a promising target in inflammation and autoimmunity","volume":"9","author":"Lee","year":"2020","journal-title":"ImmunoTargets Ther."},{"key":"10.1016\/j.rmed.2024.107721_bib27","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1034\/j.1399-3003.2000.15e14.x","article-title":"G-CSF and IL-8 but not GM-CSF correlate with severity of pulmonary neutrophilia in acute respiratory distress syndrome","volume":"15","author":"Aggarwal","year":"2000","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.rmed.2024.107721_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.jaci.2005.08.057","article-title":"The CC chemokine eotaxin\/CCL11 has a selective profibrogenic effect on human lung fibroblasts","volume":"117","author":"Puxeddu","year":"2006","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.rmed.2024.107721_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.679388","article-title":"Evaluation of pirfenidone and nintedanib in a human lung model of fibrogenesis","volume":"12","author":"Roach","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.rmed.2024.107721_bib30","doi-asserted-by":"crossref","first-page":"734","DOI":"10.7150\/ijms.43238","article-title":"The in vitro anti-fibrotic effect of Pirfenidone on human pterygium fibroblasts is associated with down-regulation of autocrine TGF-\u03b2 and MMP-1","volume":"17","author":"Tao","year":"2020","journal-title":"Int. J. Med. Sci."}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124001963?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611124001963?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,3]],"date-time":"2024-08-03T03:20:28Z","timestamp":1722655228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611124001963"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":30,"alternative-id":["S0954611124001963"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107721","relation":{},"ISSN":["0954-6111"],"issn-type":[{"value":"0954-6111","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic impact of cytokines and chemokines in bronchoalveolar lavage fluid on acute exacerbation of fibrosing interstitial lung disease","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2024.107721","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107721"}}